Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling

Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling

Abstract Aims The neutrophil‐to‐lymphocyte ratio (NLR) is a marker of systemic inflammation and plays a critical role in the assessment and prognosis in patients with heart failure. The EMPA‐HEART CardioLink‐6 trial demonstrated that patients with type 2 diabetes (T2D) and coronary artery disease (C...

Full description

Bibliographic Details
Main Authors: Raj Verma, Michael Moroney, Makoto Hibino, Cyril David Mazer, Kim A. Connelly, Andrew T. Yan, Adrian Quan, Hwee Teoh, Subodh Verma, Pankaj Puar
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:ESC Heart Failure
Subjects:
NLR
SGLT2i
Left ventricular reverse remodelling
Inflammation
Type 2 diabetes
Online Access:https://doi.org/10.1002/ehf2.14351

Internet

https://doi.org/10.1002/ehf2.14351

Similar Items